Dorin Deitch, DO
Physical Medicine & Rehabilitation · Novi, MINPI 1194174615
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 136 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AbbVie at 29.2% of the total. Reporting peaked in 2024 at $1,065 and has fallen 67.7% since, to $344 in 2025. Among physical medicine & rehabilitation clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 136 payments — averaging $25.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Medtronic$393
- Teva Pharmaceuticals USA, Inc.$382
- Scilex Pharmaceuticals Inc.$298
- Boston Scientific$275
- Merz Pharmaceuticals, LLC$237
- plus $878 from 23 others
What the payments were for
- Food & beverage$3,37997%
- Education$993%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 53 | $1,015 |
| Medtronic | 6 | $393 |
| Teva Pharmaceuticals USA, Inc. | 12 | $382 |
| Scilex Pharmaceuticals Inc. | 14 | $298 |
| Boston Scientific | 7 | $275 |
| Merz Pharmaceuticals, LLC | 7 | $237 |
| Collegium Pharmaceutical, Inc. | 6 | $123 |
| Sunovion Pharmaceuticals Inc. | 1 | $122 |
| Neurocrine Biosciences, Inc. | 6 | $119 |
| Sanofi | 1 | $107 |
| Acorda Therapeutics, Inc | 3 | $45 |
| Johnson & Johnson(2 entities) | 3 | $38 |
| Si-bone, Inc. | 1 | $32 |
| Bioventus LLC | 1 | $26 |
| Nalu Medical, Inc. | 1 | $24 |
| Averitas Pharma Inc. | 1 | $23 |
| Vertex | 1 | $21 |
| Saluda Medical Americas, Inc. | 1 | $21 |
| Greenwich Biosciences, Inc. | 1 | $19 |
| Vertos Medical, Inc. | 1 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| Abbott | 1 | $18 |
| Avanir Pharmaceuticals, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| MDD US Operations, LLC | 1 | $15 |
| SPR Therapeutics, Inc | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| GRT US Holding, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$320
- GENERAL DBS$155
- BOTOX$124
- KYNMOBI$122
- Austedo XR$121
- LUMIZYME$107
How this compares
$3,478 in reported general payments places this provider in the 90th percentile of 469 physical medicine & rehabilitation providers in Michigan.
See all physical medicine & rehabilitation providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 75 | $3,807 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 172 | $2,905 |
| Gabapentin | 284 | $1,989 |
| AmantadineAmantadine Hcl | 28 | $1,776 |
| Baclofen | 102 | $1,607 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 14 | $1,501 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 104 | $1,293 |
| Fentanyl | 12 | $784 |
| Morphine Sulfate ErMorphine Sulfate | 41 | $676 |
| Pregabalin | 59 | $660 |
| Ropinirole Hcl | 29 | $637 |
| Methocarbamol | 61 | $517 |
| Oxycodone Hcl | 46 | $423 |
| Tizanidine Hcl | 19 | $273 |
| Tramadol Hcl | 27 | $245 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Novi
- Eric KovanNovi$7K
- Michael HaenickNovi$4K
- Jenny MichaelsNovi$3K
- Edward DabrowskiRoseville$167K
- Erika ErlandsonAnn Arbor$54K
- Gianna Maria RodriguezAnn Arbor$41K
- Mathew SaffarianEast Lansing$24K
- Jason PeterTroy$20K
- David WiersemaSaginaw$17K
- Satyum ParikhWarren$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.